Maslimomab

Maslimomab is a mouse monoclonal antibody[1] and an immunosuppressive drug.[2] It is an anti-human T-cell receptor alpha/beta chain.[1]

Maslimomab
Monoclonal antibody
Type?
SourceMouse
TargetT-cell receptor
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 NY (what is this?)  (verify)

References
  1. "Proposed International Nonproprietary Names: Maslimomab" (PDF). WHO Drug Information. Geneva: World Health Organization. 5 (4): 201. 1991. Archived from the original (PDF) on 23 February 2012.
  2. Pelletier JP, Mukhtar F (January 2020). "Passive monoclonal and polyclonal antibody therapies.". Immunologic Concepts in Transfusion Medicine. Philadelphia: Elsevier. pp. 251–348 (299). doi:10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9. PMC 7153350.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.